June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
Overexpression of TMEM135 Causes Progressive RPE Atrophy Dependent on Mouse Genetic Background
Author Affiliations & Notes
  • Samuel Grindel
    Medical Genetics, University of Wisconsin-Madison, Madison, Wisconsin, United States
  • Michael Landowski
    Medical Genetics, University of Wisconsin-Madison, Madison, Wisconsin, United States
    McPherson Eye Research Institute, University of Wisconsin-Madison, Madison, Wisconsin, United States
  • Adrienne Race
    Medical Genetics, University of Wisconsin-Madison, Madison, Wisconsin, United States
  • Abigail Johnson
    Medical Genetics, University of Wisconsin-Madison, Madison, Wisconsin, United States
  • Daniel Western
    Medical Genetics, University of Wisconsin-Madison, Madison, Wisconsin, United States
  • Marvin Gao
    Medical Genetics, University of Wisconsin-Madison, Madison, Wisconsin, United States
  • Jonathan Benson
    Medical Genetics, University of Wisconsin-Madison, Madison, Wisconsin, United States
  • Evelyn Santoirre
    Medical Genetics, University of Wisconsin-Madison, Madison, Wisconsin, United States
  • Pawan Shahi
    Ophthalmology and Visual Sciences, University of Wisconsin-Madison, Madison, Wisconsin, United States
    McPherson Eye Research Institute, University of Wisconsin-Madison, Madison, Wisconsin, United States
  • Wei-Hua Lee
    Medical Genetics, University of Wisconsin-Madison, Madison, Wisconsin, United States
  • Bikash R Pattnaik
    Ophthalmology and Visual Sciences, University of Wisconsin-Madison, Madison, Wisconsin, United States
    McPherson Eye Research Institute, University of Wisconsin-Madison, Madison, Wisconsin, United States
  • Sakae Ikeda
    Medical Genetics, University of Wisconsin-Madison, Madison, Wisconsin, United States
    McPherson Eye Research Institute, University of Wisconsin-Madison, Madison, Wisconsin, United States
  • Akihiro Ikeda
    Medical Genetics, University of Wisconsin-Madison, Madison, Wisconsin, United States
    McPherson Eye Research Institute, University of Wisconsin-Madison, Madison, Wisconsin, United States
  • Footnotes
    Commercial Relationships   Samuel Grindel, None; Michael Landowski, None; Adrienne Race, None; Abigail Johnson, None; Daniel Western, None; Marvin Gao, None; Jonathan Benson, None; Evelyn Santoirre, None; Pawan Shahi, None; Wei-Hua Lee, None; Bikash Pattnaik, None; Sakae Ikeda, None; Akihiro Ikeda, None
  • Footnotes
    Support  NIH Grant R01 EY022086 and Timothy William Trout Professorship
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 3536. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Samuel Grindel, Michael Landowski, Adrienne Race, Abigail Johnson, Daniel Western, Marvin Gao, Jonathan Benson, Evelyn Santoirre, Pawan Shahi, Wei-Hua Lee, Bikash R Pattnaik, Sakae Ikeda, Akihiro Ikeda; Overexpression of TMEM135 Causes Progressive RPE Atrophy Dependent on Mouse Genetic Background. Invest. Ophthalmol. Vis. Sci. 2020;61(7):3536.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Transmembrane protein 135 (TMEM135) is a critical protein that prevents accelerated aging retinal pathologies and regulates mitochondrial dynamics in mice. Overexpression of wildtype TMEM135 increases mitochondrial fragmentation and leads to early onset age-related cardiac pathologies including cardiac hypertrophy and fibrosis. The purpose of this study was to evaluate the eyes of mice overexpressing TMEM135 (Tmem135 TG) for ocular pathologies on two different murine genetic backgrounds.

Methods : Various aged male and female Tmem135 TG mice and wildtype (WT) littermates congenic on either the C57BL/6J (B6) background or the FVB/NJ (FVB) background (without the Pde6brd1 mutation) were used for this study. Visual function was assessed by electroretinography (ERG). Eyes were collected for histology, electron microscopy, immunohistochemistry and Western blot analysis.

Results : We observed striking retinal pigmented epithelium (RPE) abnormalities in B6-Tmem135 TG mice beginning at one month of age. The phenotype consisted of larger and thinner RPE cells, displaced RPE cells within the photoreceptor outer segments, loss of the apical microvilli and basal infoldings, hypopigmentation, and vacuolization within RPE cells. Ultrastructural examination of the RPE revealed smaller mitochondria in these mice as previously observed in the cardiomyocytes of Tmem135 TG mice. These RPE changes precede retinal dysfunction, which was detected by decreased scotopic and photopic ERG responses in one-year-old B6-Tmem135 TG mice. Remarkably, no RPE abnormalities were detected in the FVB-Tmem135 TG mice.

Conclusions : Overexpression of TMEM135 causes pathologies characteristic of RPE atrophy often seen in late ‘dry’ age-related macular degeneration. These RPE pathologies are similar to the RPE phenotypes of mouse models of mitochondrial dysfunction and support a role of TMEM135 in maintaining mitochondrial homeostasis. Phenotypic difference between B6-Tmem135 TG and FVB-Tmem135 TG mice indicates the existence of genetic modifier(s). Identification of genetic modifiers will help uncover the role of TMEM135 in mitochondrial homeostasis. Our mouse model can be used to mechanistically interrogate the molecular pathways contributing to RPE atrophy development and elucidate therapeutic targets for late ‘dry’ age-related macular degeneration.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×